ArticleFrontiers in immunology2025

Peripheral blood markers predict prognosis and irAEs of stage IV driver gene-negative lung adenocarcinoma treated with ICIs.

Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.